ARTICLE | Company News
Arena, atugen technology evaluation deal
September 10, 2001 7:00 AM UTC
atugen (Berlin, Germany) will use its GeneBloc antisense platform and cellular delivery technology to down-regulate the expression of CNS gene targets supplied by ARNA. ARNA will then use the GeneBloc...